Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.66
Delayed Data
As of Jan 18
 -0.03 / -4.35%
Today’s Change
0.51
Today|||52-Week Range
1.59
+4.00%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close0.69
Today’s open0.71
Day’s range0.62 - 0.73
Volume38,045
Average volume (3 months)16,508
Market cap$9.5M
Dividend yield--
Data as of 3:58pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.01+0.68%
BVXVBiondVax Pharmaceuti...+0.02+0.38%
CYANCyanotech Corp0.000.00%
EVOKEvoke Pharma Inc-0.03-1.26%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs